Kathryn R. Starr

773 citations

16 papers · 476 indexed · h-index 13

Cellular and Molecular Neuroscience top 10%
Molecular Biology
Pharmacology top 10%
Cognitive Neuroscience top 10%
Experimental and Cognitive Psychology top 10%

Co-authors: Lee A. Dawson Mark Duxon Zoë A. Hughes J.J. Hagan N. Upton Declan N.C. Jones Christopher J. Langmead Gerd D. Bartoszyk
Topics: Neurotransmitter Receptor Influence on Behavior (10 papers)Receptor Mechanisms and Signaling (8 papers)Neuroscience and Neuropharmacology Research (6 papers)
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Endocrine and Autonomic Systems
Journals: Brain Research Journal of Medicinal Chemistry British Journal of Pharmacology
Partner nations: United Kingdom Italy Netherlands

In The Last Decade

Kathryn R. Starr

16 papers receiving 460 citations

Peers

Countries citing papers authored by Kathryn R. Starr

Since Specialization

Citations

This map shows the geographic impact of Kathryn R. Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn R. Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn R. Starr more than expected).

Fields of papers citing papers by Kathryn R. Starr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn R. Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn R. Starr. The network helps show where Kathryn R. Starr may publish in the future.

Co-authorship network of co-authors of Kathryn R. Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn R. Starr. A scholar is included among the top collaborators of Kathryn R. Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn R. Starr. Kathryn R. Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile 2019 ·Journal of Psychopharmacology ·Simon E. Ward,Mark H Harries,Laura Aldegheri,(unknown),(unknown),Lee A. Dawson,Laurent Lacroix,Joanne Pardoe,Kathryn R. Starr,(unknown),Kerry A. Waters,John Atack,Marie L. Woolley	14
2	Pharmacological characterization ofN‐[(2S)‐5‐(6‐fluoro‐3‐pyridinyl)‐2, 3‐dihydro‐1H‐inden‐2‐yl]‐2‐propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator 2016 ·British Journal of Pharmacology ·Simon E. Ward,Paul Beswick,(unknown),Lee A. Dawson,Jane Gartlon,Francesca Graziani,Declan N.C. Jones,Laurent Lacroix,M. H. Selina Mok,Beatrice Oliosi,Joanne Pardoe,Kathryn R. Starr,Marie L. Woolley,Mark H Harries	12
3	Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test 2010 ·Brain Research ·Mikhail Kalinichev,Kathryn R. Starr,Simon J. Teague,(unknown),Rod A. Porter,Hugh J. Herdon	16
4	Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory activity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Halina T. Serafinowska,Frank E. Blaney,Peter J. Lovell,(unknown),Claire M. Scott,Paul W. Smith,Kathryn R. Starr,Jeannette M. Watson	18
5	Discovery of Potent, Orally Bioavailable, Selective 5-HT_1A/B/D Receptor Antagonists 2008 ·Journal of Medicinal Chemistry ·Simon E. Ward,Peter Eddershaw,Claire M. Scott,Laurie Gordon,Peter J. Lovell,(unknown),Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Jeannette M. Watson	9
6	Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia 2007 ·Brain Research ·Melanie J. Robbins,Kathryn R. Starr,(unknown),Ellen M. Soffin,Claire Rourke,Gareth Jones,F. M. Kelly,Jay C. Strum,(unknown),(unknown),Magalie Rocheville,(unknown),Paul R. Murdock,Declan N.C. Jones,James N.C. Kew,Peter R. Maycox	48
7	Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B 2007 ·Psychopharmacology ·Zoë A. Hughes,Kathryn R. Starr,Claire M. Scott,(unknown),Trevor Sharp,Jeannette M. Watson,Jim J. Hagan,Lee A. Dawson	23
8	SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test 2007 ·Neuropsychopharmacology ·Kathryn R. Starr,Gary Price,Jeannette M. Watson,Peter J. Atkinson,Roberto Arban,Sergio Melotto,Lee A. Dawson,Jim J. Hagan,Neil Upton,Mark Duxon	43
9	3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Peter J. Lovell,Frank E. Blaney,(unknown),Claire M. Scott,Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Antonio Vong,Simon E. Ward,Jeannette M. Watson	13
10	SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT1B receptor antagonist 2006 ·Neuropharmacology ·Claire M. Scott,Christopher J. Langmead,(unknown),Paul Wyman,Paul W. Smith,Kathryn R. Starr,Lee A. Dawson,Gary Price,J.J. Hagan,Jeannette M. Watson	5
11	Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity 2006 ·Neuropharmacology ·Lee A. Dawson,Zoë A. Hughes,Kathryn R. Starr,(unknown),(unknown),(unknown),Roberto Arban,(unknown),Sergio Melotto,J.J. Hagan,Gary Price	32
12	Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data 2005 ·Psychopharmacology ·Claire Rourke,Kathryn R. Starr,Charlie Reavill,(unknown),(unknown),Declan N.C. Jones	18
13	A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Steven M. Bromidge,David Clapham,Frank D. King,Peter J. Lovell,(unknown),(unknown),Vicky Holland,Graham J. Riley,Kathryn R. Starr,Brenda Trail,Martyn Wood	14
14	Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone 2005 ·European Journal of Pharmacology ·Zoë A. Hughes,Kathryn R. Starr,Christopher J. Langmead,Matthew Hill,Gerd D. Bartoszyk,J.J. Hagan,Derek N. Middlemiss,Lee A. Dawson	94
15	Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement 2001 ·Psychopharmacology ·Mark Duxon,(unknown),Kathryn R. Starr,Declan N.C. Jones,Vicky Holland,Graham J. Riley,Jeff Jerman,Stephen Brough,Darren Smart,Amanda Johns,Wai N. Chan,Rod A. Porter,Neil Upton	79
16	Latency to paroxetine‐induced anxiolysis in the rat is reduced by co‐administration of the 5‐HT_1A receptor antagonist WAY100635 2000 ·British Journal of Pharmacology ·Mark Duxon,Kathryn R. Starr,N. Upton	38

About Kathryn R. Starr

Kathryn R. Starr is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry, having authored 16 papers that have together received 476 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). The work is most often cited by research in Biological Psychiatry (54 citations), Cellular and Molecular Neuroscience (246 citations) and Endocrine and Autonomic Systems (77 citations). Kathryn R. Starr has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Lee A. Dawson, Mark Duxon, Zoë A. Hughes, J.J. Hagan, N. Upton, Declan N.C. Jones, Christopher J. Langmead, Gerd D. Bartoszyk, Jeannette M. Watson and Derek N. Middlemiss. Their work appears in journals such as Brain Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact